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Laminins (LM) are extracellular matrix molecules that contrib-
ute to and are required for the formation of basement
membranes. They participate in the modulation of epithelial/
mesenchymal interactions and are implicated in organoge-
nesis and maintenance of organ homeostasis. Among the LM
molecules, the LM a5 chain (LMa5) is one of the most widely
distributed LM in the developing and mature organism. Its
presence in some basement membranes during embryoge-
nesis is absolutely required for maintenance of basement
membrane integrity and thus for proper organogenesis. LMa5
also regulates the expression of genes important for major
biological processes, in part by repressing or activating
signaling pathways, depending upon the physiological
context.
Introduction
Development and homeostasis of organisms are complex processes
requiring interactions between cells and the extracellular matrix
(ECM). Basement membranes are specialized ECMs that play a
mechanical supporting role for various cell types and also mediate
interactions between epithelial sheets and the adjacent mesenchy-
me or stroma. Among the major basement membrane proteins,
laminins (LM) have been shown to regulate cell adhesion,
migration and differentiation. LM are composed of a, β and c
chains that assemble into aβc heterotrimers to form 16 different
isoforms.1 Each heterotrimer is assigned a three digit Arabic
numeral based on the respective aβc chain composition.2 The
laminin a5 (LMa5) chain is one of the major a chains in the
epithelial basement membranes of developing and adult organs.3,4
Diverse experimental approaches, such as cell culture on LM-
511 (a5β1c1) or LM-521 (a5β2c1) substrates, knockout of
LMa5, and generation of LMa5 transgenic mice have been
employed to study this LM chain. The importance of LMa5 in
morphogenesis was demonstrated by the embryonic lethality of
Lama5 knockout mice at ~17 d of embryonic development.
Embryos lacking LMa5 exhibit multiple developmental defects,
including failure of anterior neural tube closure (exencephaly),
failure of digit septation (syndactyly) and dysmorphogenesis of the
placental labyrinth.4 Although mutations in LAMA5 have not yet
been described in human pathologies, alterations of LMa5 have
been reported to be associated with Crohn disease, Hirschsprung
disease and tufting enteropathy.5
Here we review the current literature devoted to studies of the
role of LMa5 in development and homeostasis of various organs
and summarize the possible signaling pathways that are triggered
by LM-511/-521. The potential contributions of LMa5 chain to
vascular homeostasis are discussed elsewhere in this issue by
Yousif et al., and the implications of LMa5 for regulating tumor
cell migration, invasion and metastasis are discussed by Pouliot
and Kusuma.
The Laminin a5 Chain
Although LMa5 was first visualized on protein gels and in tissues
as a presumed component of a LM trimer, its actual identity was
not known until it was cloned by RT-PCR using degenerate
oligonucleotides designed to amplify any LM a chain cDNA from
mouse kidney. The mature mouse LMa5 protein is composed of
~3,630 amino acids and has a molecular weight of approximately
400 kDa.3 Northern blot analysis reveals a single band of ~11 kb
in most organs studied,6-8 although an additional 13 kb band was
found in certain mouse organs, including lung and kidney.7
Comparison between the human (3,695 amino acids) and the
mouse LMa5 sequence shows an overall amino acid identity of
79%.9 In Drosophila, the LMa3,5 chain is most similar to
vertebrate a3 and a5 and is part of the laminin A trimer.10 Studies
of the origin of LM suggest that the early evolution of this family
of molecules involved duplication and extensive domain
rearrangement.11
LMa5 (Fig. 1) is very widely expressed in mammalian tissues.
Through a combination of immunoprecipitation, non-denaturing
gel electrophoresis, mass spectroscopy, and colocalization experi-
ments using chain-specific antibodies, it has been shown that the
a5 chain can combine with β1, β2, c1 and c3 chains to form three
distinct isoforms: LM-511 (in basement membranes underlying
epithelium, endothelium and smooth muscle), LM-521 (in
basement membranes of epithelium, endothelium, smooth muscle,
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neuromuscular junctions and kidney glomerulus) and LM-523 (in
the retina and central nervous system).1,2,12 The existence of LM-
522 (a5β2c2), reported so far solely in bone marrow,13 was not
confirmed in a complete analysis of LM chain assembly using
recombinant coiled-coil fragments of the LMc2 domain.12
Each LMa5-containing trimer appears as a cross-like structure,
similar to most other LM heterotrimers. The base of the cross is
formed by the C-terminal part of the a chain called the laminin
globular (LG) domain, which is subdivided into five globular
subdomains (LG1-LG5).14 The LG domain represents the
principal site for interactions with cell surface receptors, whereas
the short arm of a5 contains the laminin N-terminal (LN)
domain, which is involved in spontaneous heterotrimer poly-
merization via intertrimer interactions with LN domains present
in the β and c chains.15,16 A recent study using Biacore analysis
investigated the nature of the bonds formed among LM subunits
and identified the amino acids involved by analyzing the crystal
structure of the a5 LN domain.17 In the skin it has been
hypothesized that LM-511 and LM-521 can co-polymerize by
interactions among the LN domains; lateral aggregation will then
occur to allow further polymerization into a heterotypic LM
superstructure that is also capable of integrating LM-332, which
lacks typical LN domains. Then, the separate LM and collagen IV
networks can be connected either by nidogen or perlecan.16,18
Receptors for the LMa5 Chain
The functionality of extracellular LM is mediated through
interactions with cell membrane receptors. The best-established
type of LM receptor is the integrin family, which plays a central
role in cell-matrix interactions in most tissues. Besides integrins,
LM can also bind to more specific receptors, depending on the
tissue or the constituent a chain. Regarding LMa5 (Fig. 1), it is
known to bind specifically to particular integrins, to a-
dystroglycan, to syndecan-4, and to the Lutheran/basal cell
adhesion molecule (Lu/B-CAM).19
Integrins. Integrins are transmembrane aβ heterodimers.
Eighteen a and eight β subunits are known, generating 24
heterodimers.20,21 They form a superfamily of cell adhesion
receptors that bind to extracellular matrix ligands, cell-surface
ligands and soluble ligands. Integrins can function as traction
receptors that can transmit and detect changes in mechanical
forces acting on the ECM. Some integrins are limited to certain
cell types or tissues, whereas others are widely distributed. In
regard to ligand specificity, integrins can be grouped into laminin-
binding integrins, collagen-binding integrins, leukocyte integrins
and RGD-recognizing integrins. Among the laminin-binding
integrins, the LMa5 chain can potentially bind the a2β1, a3β1,
a6β1, a6β4, a7β1 and avβ3 integrins.1,22,23 Interestingly, double
homozygous integrin a3/a6-null mouse embryos show deve-
lopmental phenotypes similar to those observed in LMa5-null
embryos, suggesting that these two integrin subunits are part of
the major receptors for LM-511/-521 during development and
that the interaction of LMa5 with these receptors is essential for
the development of certain tissues.24
a-dystroglycan and syndecan-4. Dystroglycan is a member of
the dystrophin-glycoprotein complex, a large complex of plasma
membrane-associated proteins that is critical for the integrity of
skeletal muscle fibers. Dystroglycan is composed of an a and a β
subunit encoded by a single gene, DAG1 (dystrophin-associated
glycoprotein 1), and it provides a link between the ECM and the
cytoskeleton (for review, see ref. 25). Dystroglycan is mainly
expressed in skeletal muscle, in the central and peripheral nervous
systems, as well as in the retina and in a subset of epithelial cells.
Besides its high affinity binding to LMa1 and a2 chains, a-
dystroglycan was also shown to bind to a recombinant LMa5
fragment, supporting the idea that this receptor could work as a
LM receptor in vivo.26 Very little is known about the signaling
mediated by the binding of LMa5 to a-dystroglycan, except that
it could inhibit extracellular-signal-regulated kinase (ERK)
activation, in contrary to the binding of LMa5 to integrin
a6β1, which activates ERK.27
Syndecans are transmembrane heparan sulfate proteoglycans.
Four syndecans (syndecan-1 to -4) have been identified in
Figure 1. Schematic representation of LMa5 binding sites for its major
receptors. Binding sites to known cellular receptors interacting with the
LMa5 chain are depicted on the main functional domains LN and LG
(LG1-LG5). The LG3 module (*) is indispensable for a3b1 and a6b1
binding; the precise binding site for a6b4 integrin (w) has not been
determined.























mammals, and the expression of each is developmental stage- and
cell type-specific. Among the syndecans, syndecan-4 is widely
distributed in development, expressed in many different cell
types.28 When adhesion assays were performed with conjunctival
epithelial cells on a peptide from the LG4 domain of LMa5, an
antibody to the ectodomain of syndecan-4 inhibited adhesion to
the peptide. In addition, cells adhering to this peptide showed
increased phosphorylation of focal adhesion kinase (FAK). These
results suggest that cell adhesion to a peptide from the LMa5
LG4 domain results in increased tyrosine phosphorylation of FAK
through binding to syndecan-4.29
Lutheran/B-CAM. The Lutheran blood group antigen (Lu) is a
transmembrane glycoprotein that belongs to the immunoglobulin
superfamily.30,31 This receptor is also known as basal cell adhesion
molecule (B-CAM). In contrast to the integrins that can bind
several ECM molecules, Lu only binds to laminin isoforms
containing the a5 chain.32 Supporting this, it was shown that Lu/B-
CAM expression is dramatically reduced in tissues from mouse
embryos lacking LMa5, while it is significantly increased in the
hearts of transgenic mice overexpressing LMa5.33 Similarly, in the
intestines of LMa5 deficient mice, there was decreased Lu staining,
especially in the muscle region where LMa5 is usually present at
high levels.34 Using a soluble recombinant protein containing the
Lu extracellular domain, Kikkawa and colleagues demonstrated
specific binding of Lu to LM-511/521.32 The recombinant protein
used as a probe was also able to bind LMa5-containing basement
membranes in normal but not in LMa5 knockout tissue sections.
But surprisingly, mice with targeted disruption of the Lu gene are
viable, fertile, and appear healthy with no major defects in organ
development or function. However, loss of Lu causes structural
alterations in the kidney (thickening of the glomerular basement
membrane) and intestine (enlargement of the smooth muscle layers
and abnormal organization of the cells).35,36
Binding sites for LMa5 receptors. Binding sites for receptors
have been reported to be localized to three regions of the LMa5
chain. The C-terminal LG domain appears to be the major one
(Fig. 1), as there are multiple lines of evidence both in vitro and in
vivo, but the N-terminal LN domain and the L4 domain present
in the central part of the molecule have also been implicated in a
few studies.
Concerning the LG domain, in vivo experiments using
transgenic mice expressing full length and chimeric laminin a5/
a1 chains on the LMa5 null-background revealed that the LG1–2
tandem harbors most of the functionality of the a5LG domain for
developmental processes, while the a5LG3–5 tandem is somehow
involved in maintaining integrity of the glomerular filtration
barrier.37,38 To understand which subdomain is specific for which
receptor, antibody-inhibition assays performed on two a5LG
fragments showed that a3β1 and a6β1 integrins bind to the
LG1–3 domain.39 Interestingly, the LG3 module is indispensable
for binding to a3β1 and a6β1 integrins, but this module alone is
not sufficient to recapitulate integrin binding activity.40 Moreover,
by producing a large series of recombinant LM trimers containing
modified chimeric a1/a5 chains, it was determined that only a
complete a5LG1–3 tandem with the LCC (laminin coiled coil)
domain could reproduce the activity of Lu/B-CAM binding to
LMa5. This specific binding site may overlap with that of
integrins a3β1 and a6β1, as soluble Lutheran can inhibit
integrin-mediated cell adhesion to LMa5.41 The binding site for
a6β4 integrin has not yet been characterized, but comparison
with LMa1 suggests that this integrin may also bind the LMa5
LG1–3 domain.22 Furthermore it was demonstrated that a-
dystroglycan and syndecan-4 binding was localized to the LG4
domain.29,39,40
Regarding receptor binding sites on the a5LN domain
(previously known as domain VI), experiments using integrin
blocking antibodies demonstrated a3β1 to potentially be a major
receptor. Unexpectedly, weak interactions with integrins contai-
ning the a2, a4 and a6 subunits were also found. Furthermore,
heparin could inhibit cellular binding to the LN domain by
~90%, suggesting a potential role for syndecans and/or a-
dystroglycan in mediating adhesion.42 Finally, the LMa5 L4b
domain (previously called domain IVa) contains two RGD
sequences (Arg-Gly-Asp; conserved in human LMa5) that could
theoretically contribute to cell adhesion. Antibodies against
integrins β1, avβ5 or a5 partially inhibited specific binding to
this domain, whereas antibodies against av, a3 or a6 integrins
had either no or only a marginal effect.43 Binding to those
integrins was rather surprising, since some of them are not
classical LM receptors. One hypothesis could be that the L4
domain of LMa5 represents a cryptic site, but whether and how it
is released from or exposed on the intact molecule is not known.
LMa5 Can Trigger Either Stem Cell Renewal
or Differentiation
Recently, there has been significant interest in developing defined
feeder cell-free in vitro culture systems for the establishment and
maintenance of undifferentiated mammalian ES cells. The goal is
to identify appropriate substrates suitable for promoting self-
renewal of embryonic stem cells (ES) without loss of pluripotency.
Matrigel that contains LM-111 is the most common non-feeder
cell coating used so far for human ES (hES) cell cultures. As the
LMa5 chain contacts the inner cell mass of blastocysts, which is
the natural origin of ES cells, some groups investigated whether
LM-511 may be useful for culturing ES cells. The first attempts
tested specific LM isoforms for their ability to serve as substrates
for maintaining mouse ES cells in the absence of any
differentiation inhibitors or feeder cells.44 Only when mouse ES
cells were cultured on LM-511 were they able to self-renew for up
to 31 passages, without undergoing differentiation. Under these
conditions, LM-511 allowed expansion of pluripotent cells, as
assessed by the expression of markers such as Oct4, Sox2 or
Nanog, and they could contribute to various mouse tissues in
chimeras upon blastocyst injection. The same investigators later
used recombinant human LM-511 for the culture of hES cells.
The hES cells exhibited more spreading behavior on LM-511 as
compared with other LM isoforms or to Matrigel. The hES cells
could be maintained on LM-511 for more than 20 passages,
expressed hES cell markers (Oct4), and, most importantly,
retained pluripotency as demonstrated by teratoma formation.
Using function-blocking antibodies, they showed that the binding























of hES cells to LM-511 is solely through integrin a6β1.45 In
parallel, Hongisto and colleagues studied the characteristics of
various types of hES cells feeder cells, and showed that the cells
that supported the maintenance of hES pluripotency indeed
produced LM-511 and expressed an appropriate set of LM-
binding integrins (a3β1, a6β1 and a7β1).46
Regarding the fact that ECM is also important for cell
differentiation, a new approach is to use LM-511 to help ES cells
or induced pluripotent stem (iPS) cells to differentiate into a
particular cell type under defined culture conditions. Using a
synthesized basement membrane substratum containing LM-511
(derived from HEK293 cells stably expressing LM-511),
differentiation of mouse ES or iPS cells into definitive endoderm
and further to insulin-expressing pancreatic β-cells in vitro was
achieved.47 When β1 integrin was knocked-down in differen-
tiating ES cells, a significantly reduced proportion of pancreatic
cells was observed, suggesting that the guiding signal from the
LM-511-enriched matrix was transduced through β1 integrin.
Similarly, the ability of this LM-511 substratum to support
hepatic differentiation of both mouse and human ES cells was
shown to involve integrin β1 and Akt signaling activation.48
These studies indicate that LM-511, alone or in combination
with other molecules, plays a dual role in both the maintenance/
renewal of ES cells and in their differentiation into particular cell
lineages in vitro, depending upon the culture context.
LMa5 and Tissue Patterning during Development
The LMa5 chain is required during embryogenesis (Fig. 2), as
shown by the embryonic lethality of the Lama5 knockout. LMa5
is present in virtually all basement membranes of early somite
stage embryos and then becomes restricted to specific basement
membranes as development proceeds, including those of the
surface ectoderm and placental vasculature.4 LMa5 plays multiple
roles in various processes of early embryogenesis: structural
support, adhesion, stop signal; yet it is also important in cell
renewal and/or differentiation.
LMa5 expression during implantation. Implantation of the
mammalian embryo into the uterus requires changes in adhesive cell
molecules. LM-511 and LM-111 are the major isoforms expressed in
the embryo and the uterine decidua during implantation.49,50 In the
uterus, LMa5 is strongly expressed in the decidualizing matrix of the
stroma.49 In the implanting blastocyst, LMa5 is expressed only in the
inner cell mass and the polar trophectoderm.50 During implantation,
LMa5 promotes spreading and persistent migration, as assessed by
culturing trophoblasts on LM-511 substrata.51 Although the roles of
each LM chain appear to generally be distinct, it has been shown that
LMa5 can partially compensate for the absence of LMa1 in
embryonic basement membrane formation, and can promote
embryonic ectoderm cavitation and parietal endoderm differenti-
ation.50,52 Moreover, overexpression of LMa5 from a transgene in
LMa1 null-embryos is able to rescue the phenotype until the
initiation of gastrulation, but it fails to rescue Reichert’s membrane.50
LMa5 is involved in the establishment of the placenta. In
LMa5 knockout mice, the placental labyrinth was clearly
malformed, in contrast to Reichert’s membrane or yolk sac, two
other extraembryonic tissues that were unaffected in Lama5
mutants. The placental labyrinth is composed of trophoblasts and
endothelial cells that derive from the embryo. Normally, a
basement membrane that is rich in LMa5 separates the
endothelium (which forms the vessels through which the
embryonic blood circulates) from the trophoblast layer. In Lama5
mutants, the labyrinth is significantly smaller and underdeveloped.
The network of fetal blood vessels is present and associated with a
basement membrane, but the complexity of vessel branching is
greatly reduced. These defects reduce the surface area available for
exchange of molecules between the fetal and maternal blood-
streams, which probably leads to placental insufficiency in mutants,
and then to embryonic lethality. Additionally, an ultrastructural
study of the mutant labyrinth showed that endothelial cells and
trophoblasts become separated by a cell-free space due to
detachment of the trophoblasts from the intervening basement
membrane, which is discontinuous and of heterogeneous thickness.
These data suggest that the LMa5 chain is necessary to maintain
trophoblast adhesion to the basement membrane and to promote
blood vessel branching in the placenta.4 Interestingly, Kikkawa and
colleagues generated mice expressing chimeric LMa5/a1 chains
with different LMa5 LG domains on the LMa5 null background.
By this approach they could show that expression of chains
containing the LMa5 LG1-LG2 tandem were able to rescue
placental vascularization, probably through a binding site recog-
nized by a trophoblast cell surface receptor.38
LMa5 defect leads to exencephaly. One of the most dramatic
developmental defects of Lama5-null mice is exencephaly. This
phenotype appears in approximately 60% of mutant fetuses.4
Exencephaly is caused by a failure in anterior neural tube closure.
This results in an “inside out” neuroepithelium, meaning that the
proliferative cells are found on the outer surface. In mutant mice,
the ectodermal basement membrane was thin and patchy at the
peak of the neural folds. The authors concluded that weakness of
the basement membrane in this region decreased the amount of
lateral forces the ectoderm could generate on the neural folds,
thereby leading to sporadic failure of cranial neural tube closure.4
LMa5 influences neural crest cell migration. In addition to
the exencephaly, LMa5 null-mice exhibit craniofacial abnorma-
lities that can result from abnormal neural crest migration.
Separation of neural crest cells from the dorsal neural epithelium
and their migration involve alterations in cell-cell adhesion but
also in cell-matrix interactions. While it was already shown that
ECM molecules are involved in neural crest cell migration,53
investigating the function of LMa5 in this embryonic process was
undertaken by Coles and colleagues.54 Although changes in LMa5
expression levels precede neural crest cell migration,55 LMa5
appears not to be implicated in the initiation of migration, since
no differences were observed between wild type and Lama5-null
embryos. Yet, in LMa5 null-mice, an expansion in neural crest
migratory streams was observed, suggesting that LMa5 normally
restricts neural crest migration pathways. This is corroborated by
in vitro data showing that a LMa5-containing substratum was
able to reduce cranial neural crest cell migration.54 Examination of
Lama5 transcripts in chick and mouse to identify the migratory
paths showed that these transcripts had minimal overlap with























migratory neural crest cells. These data support the hypothesis
that LMa5 may act as a non-permissive or inhibitory signal that
restricts and/or guides neural crest cells to defined routes.
Limb defects occur in the absence of LMa5. Syndactyly (failed
digit separation) is one of the most severe and visible defects
observed in the LMa5 null-mice. This defect is visible at E12.5,
as soon as septation normally begins. Until E9, the ectodermal
and dermal layers appear similar in mutants and controls. Like the
cranial defect, syndactyly is associated with localized structural
deficiencies in regions of basement membrane that are likely to be
subjected to greater mechanical stress than are neighboring
regions. In mutants, the outgrowth that normally occurs in the
distal portion of the limb bud (under the direction of the apical
ectodermal ridge) may stress the LMa5 deficient basement
membrane, leading in turn to rupture of the overlying ectoderm
and extrusion of mesenchymal cells onto the outer surface of the
distal limb. This is a mechanical explanation for the defect, but
one cannot exclude the deregulation of signaling pathways linked
to the absence of LMa5.4
Implications of Laminin a5 in Organogenesis
Although Lama5 expression is regulated both temporally and
spatially during development, its expression can still be described
as widespread, as LMa5 is found in many fetal and adult tissues
including salivary gland, lung, kidney, skin, tooth and intestine
(Fig. 2). Several defects that will be summarized here were
observed in internal organs of Lama5 null-embryos,4 arguing for a
major role for LMa5-containing molecules during organogenesis.
Additional studies suggest that LMa5 is important in the
maintenance of homeostasis in mature tissues.
LMa5 controls lobular ramification of the submandibular
gland. Branching morphogenesis is a key developmental process
that leads to organ growth as well as increased surface area for
efficient gas or fluid exchange across an epithelium in organs such
as the lung, kidney (ureteric bud), mammary gland and salivary
gland. One of the classic and well-described systems for studying
branching morphogenesis is the mouse embryonic submandibular
salivary gland, which develops via repetitive bifurcations of a
cluster of epithelial cells that leads to formation of a tree-like duct
system. At the ends of the ducts, buds differentiate into acini that
contain well-polarized secretory cells surrounded by myo-
epithelial cells. At the beginning of gland formation (at E13),
LMa5 is found in the basement membrane underlying the acini
and the duct, when ducts and buds are emerging.56
The first strategy used to test if LMa5 could play a role in
development was to screen LMa5 LG domain peptides for their
ability to interfere with branching morphogenesis of cultured
submandibular glands. These in vitro experiments suggested that
one peptide derived from the LG4 domain (A5G77) was crucial,
as it inhibited epithelial morphogenesis, although, surprisingly, a
continuous intact basement membrane was still present. Peptides
corresponding to the A5G77 sequence but derived from other
LMa chains (a1, a3 or a4) did not inhibit epithelial branching,
Figure 2. A diagrammatic summary of the diverse developmental processes in which LM-511 and the basement membranes that contain it are involved.
Results from studies of Lama5 mutant mice, transgenic mice, and cells cultured on LMa5-containing substrates reveal roles in organogenesis (left) and
early developmental events (right). See text for details.























suggesting for the specificity of action of the LMa5 peptide.56 In a
different strategy, examination of Lama5−/− mice revealed that the
submandibular glands were developmentally delayed at E13; the
first round of cleft formation and branching had not occurred,
although the end bud was enlarged, and the sublingual salivary
gland had not formed.57 Finally, addition of Lama5-siRNA to
wild-type submandibular gland explants in culture decreases
branching morphogenesis, clearly indicating that LMa5 controls
the lobular ramification of the salivary gland.57
LMa5 is required for complete lung lobar septation but not
for lung branching morphogenesis. A major role for LM in lung
branching morphogenesis was first identified by Schuger and
colleagues, who showed that polyclonal antibodies to LM
(recognizing several isoforms, including LM-511) inhibit lung
morphogenesis when added to organotypic cultures of mouse
embryonic lung.58 In situ hybridization revealed the presence of
LAMA5 transcripts throughout human lung development, with
preferential expression in the alveolar type II cells, similar to
mouse lung.7,8 Antibodies to LMa5 stain nearly all basement
membranes of the lung, including alveolar and visceral pleural
basement membranes, showing that the expression of the protein
is continuous from early lung development through adult life.8 In
LMa5 null-mice, there is incomplete lobar septation and absence
of the visceral pleura basement membrane, whereas lung
branching morphogenesis and vasculogenesis are normal.59 In
contrast, in other branching organs such as salivary glands or
kidney, alterations of morphogenesis were reported.57,60 One
explanation offered is that the normal branching morphogenesis
observed in the Lama5-null lung is probably due to compensation
linked to ectopic deposition of LMa4 in the airway basement
membrane.59 The defect in lobar septation is clearly linked to the
absence of LMa5 and subsequently to the lack of the pleural
basement membrane, as LMa5 was found to be the only LMa
chain present in the normal visceral pleura. As LMa5 null-mice
are embryonic lethal, an inducible lung epithelial cell-specific
LMa5 deletion was generated.61 Using the human surfactant
protein C promoter, the reverse tetracycline transactivator, and
the Cre/LoxP system, mice lacking LMa5 in lung epithelial cells
survived to birth. But more significant defects in lung
morphogenesis were observed, including dilated airspaces,
perturbed epithelial cell differentiation (reduction or even absence
of alveolar cells) and decreased proliferation. Expression of a3
integrin was increased, raising the hypothesis that epithelial cells
may attempt to compensate for the lack of interaction with its
ligand (a situation also observed in LMa5 null-intestine34). Finally
the Lama5-deficient lungs also showed a decrease in VEGF
production (normally expressed by alveolar cells), which might
explain the vascular defects observed in the mutants.61
LMa5 in kidney development and function. The kidney is an
organ rich in basement membranes that is particularly dependent
on LMa5 for proper development and function due to its
deposition in practically all kidney basement membranes. In
Lama5 null-embryos, there is a low incidence of renal agenesis,
usually unilateral, for unknown reasons.60 Although the kidneys
that do form in these mutants are of practically normal size, when
grown in organ culture there is a defect in ureteric bud branching
morphogenesis, suggesting that LM-511 in the early ureteric bud
basement membrane could be important for providing morpho-
genetic signals, as discussed above for salivary gland. Although
renal agenesis is a partially penetrant phenotype in Lama5 null-
embryos, kidneys that do form exhibit failed vascularization of
glomeruli, the part of the nephron that filters the blood.60 Thus,
Lama5 null-kidneys cannot filter the blood or produce urine and
so are nonfunctional. Ultrastructural analysis of the developing
glomerulus shows that the glomerular basement membrane
(GBM), a normal component of the filtration barrier, breaks
down in the absence of LMa5. This leads to disorganization of
the three cell types that are necessary to form the glomerular
capillaries: podocytes, endothelial cells, and mesangial cells.
Results from several studies suggest that the LG domain of
LMa5 in the GBM is normally bound by a3β1 integrin on
podocytes and mesangial cells.37,38 Exactly how endothelial cells
adhere to the GBM is not known.
LMa5 is not only important for development of the kidney and
the glomerular vasculature; it is also a crucial component of the
glomerular filtration barrier to plasma albumin, due to its
presence in the mature GBM as part of the LM-521 trimer.
Replacement of the a5LG3–5 domain with that of a1 results in
leakage of albumin across the GBM,38 as does podocyte specific
knockout of Lama5 using the Cre/loxP system.62 Mutations that
affect expression of laminin β2 in humans and mice also cause
leakage of plasma albumin, likely due to reduced overall levels of
LM-521 trimers in the GBM that could lead to increased
porosity.63-65
LMa5 promotes hair follicle development. The skin contains
hair follicles formed during embryogenesis as appendages of the
epidermis. As in other organs, epithelial-mesenchymal crosstalk is
required to complete morphogenesis and differentiation, and
basement membrane molecules are possible mediators involved in
this communication.66 LM-511 (assessed by immunostaining
with anti-a5, anti-β1 and c1) was prominently expressed in the
specialized basement membrane of elongating hair germs, which
lacked LMa1, β2 and LM-332.67 The first evidence showing that
LM-511 plays an important role in hair development was
provided by injection of anti-human LMa5/LM-511 blocking
antibody into nude mice bearing embryonic human scalp skin
xenografts. The circulating antibody targeted the xenografts and
produced alopecia (loss of hair).67 As a next step, the authors
examined embryonic Lama5 null mouse skin and showed that it
contained fewer hair germs. Upon further development of E16.5
skin after grafting, it was shown that hair germs of Lama5−/− skin
progressively underwent complete regression. Interestingly, this
phenotype was restored by applying exogenous LM-511 to
mutant skin prior to grafting.67-69 Similarly, in mature hair follicle
cultures, addition of human LM-511/521 enhanced hair growth,
suggesting that LM-511 is crucial not only for initial hair
morphogenesis, but also for hair growth in the adult. Given that,
the authors hypothesized that the gradual loss of LM-511 from
the epidermal basement membrane with aging70 could be
responsible in part for age-related hair loss.71
LMa5 has been described to be a potent adhesive ligand for
keratinocytes through binding to integrins a3β1 and a6β4.























LMa5 also regulates keratinocyte proliferation and migration,
suggesting a role in normal epithelial replacement, wound healing
and tumor growth.70 A microarray analysis designed to discover
genes expressed by human dermal pericytes that could potentially
promote epidermal regeneration identified the LAMA5 gene.
Moreover, LMa5 deposition into the dermal space was shown to
derive from pericytes. Hence, it was concluded that pericytes
compensate for the inherently decreased levels of LMa5
synthetized by differentiating keratinocytes, thereby promoting
epidermal regeneration.72
LMa5 promotes cell proliferation in the developing tooth.
Tooth morphogenesis in mice starts at E11.5, when the oral
ectoderm invaginates into the underlying mesenchyme. This
process results in the formation of epithelial tooth buds. A
homogeneous strong expression of Lama5 transcripts, confined to
the epithelia but not to the dental mesenchyme, was seen
throughout several stages of tooth development, although its
expression was downregulated as development proceeded. The
corresponding LMa5 protein is the major LM in the tooth
basement membrane and showed an even distribution.73 Lama5-
null mice presented with basement membrane disorganization and
corresponding defects in tooth germ development. Defects include
smaller tooth germs with defective cusp formation and impaired
polarity of the inner dental epithelium. Proliferation of the dental
epithelium was reduced, and consistent with this in vivo finding,
a5-containing LM trimers (-511/-521) were able to promote
proliferation of primary cultures of dental epithelial cells.74
Absence of LMa5 in the intestine leads to morphological
defects. The development and homeostasis of the intestine are
mainly regulated by interactions between cells and the extra-
cellular matrix. The deficiency of LMa5 in the intestine leads to
morphological and biochemical alterations in the smooth muscle
layer, whereas no obvious morphological defects were observed in
villous outgrowth and crypt formation, probably due to a
compensatory mechanism involving the overproduction of other
LMa chains (i.e., overexpression of LMa4 and ectopic expression
of LMa2 in the epithelial basement membrane). However,
excessive folding of the intestinal loops was observed in LMa5
null-mice that could lead to fusion of the muscular layers in the
most severe cases.34 Due to the embryonic lethality of LMa5 null-
mice, two strategies have been used to allow generation of
intestines at later stages. The first was the engrafting of LMa5−/−
intestinal fragments into the subcutaneous space of adult nude
mice.34 Unfortunately, here again a compensatory phenomenon
occurred, as LM a2, a4, and a1 were deposited into the
LMa5-deficient basement membrane. The second strategy
consisted of a transgenic rescue of the LMa5 null mice by
crossing them with transgenic mice expressing a full-length mouse
LMa5 transgene. The LMa5 transgene was widely expressed in
several organs but was silenced in the intestine after embryogen-
esis.75 Interestingly, the diminution of LMa5 in the intestine at
later developmental stages led to drastic morphological changes in
the mature intestinal architecture with many similarities to a
colon-like phenotype. These changes included disruptions of
normal crypt-villus architecture with fusion of villi and an increase
in the number of goblet cells.75,76
Cellular Origins of the Laminin a5 Chain
Basement membrane assembly in many cases requires intimate
contact of both epithelial cells and stromal cells, as exemplified in
the intestine. In contrast to the original notion that the basement
membrane was strictly of epithelial origin, it has become clear that
some molecules, including LM, can be of mesenchymal origin.76
In the intestine, the origin of the LMa5 chain was studied during
development by creating hybrid intestines consisting of mouse
and chick endodermal or mesenchymal tissues. Deposition of a5
in well-developed hybrid intestines was then assayed by mouse-
specific LMa5 antibodies. This experiment demonstrated that
both epithelial and mesenchymal cells synthesize and deposit the
LMa5 chain into the basement membrane. The LMa5 chain
produced by each cell type depended on the developmental stage
and location along the crypt-villus axis; in the crypt region (where
cell proliferation occurs), LMa5 is predominantly produced by
the mesenchyme, and in the villus (where cells migrate and
differentiate) it is predominantly produced by the endoderm
(epithelium).6 In LMa5 knockout mice, a compensation process
takes place in which a2 and a4 laminins are deposited
precociously or ectopically by mesenchymal cells.6,76
Similar to the intestine, there is a mesenchymal contribution to
the skin’s epidermal basement membrane.77 Fetal bovine
keratinocytes cultured on collagen gels without fibroblasts were
unable to produce an ultrastructurally recognizable basement
membrane, whereas the addition of dermal fibroblasts facilitated
basement membrane formation. When dual species cultures of
bovine keratinocytes and human fibroblasts were analyzed by
immunofluorescence with human specific antibodies, dermal
fibroblasts were shown to synthesize and deposit LMa5 in a linear
manner into the basement membrane zone.77 Therefore it is likely
that the hypothesized necessity of heterotypic cell/cell interactions
for basement membrane formation will be applicable to other
organs. This is exemplified by the fact that there is an
upregulation of Lama5 mRNA levels in endothelial/pericyte
cocultures as compared with endothelial cells or pericytes cultured
alone.78
As discussed above, the kidney glomerular basement membrane
is situated between endothelial cells and podocytes, also known as
visceral epithelial cells. It is clear that both podocytes and
endothelial cells synthesize the LMa5 in the GBM, and that as
long as one of the two cell types is able to synthesize it, then GBM
structure is maintained and vascularization can occur.79,80
Similarly, in the placental labyrinth, the vascular basement
membranes containing LMa5 lie between the fetal endothelial
cells and the trophoblasts. Although both trophoblasts and
endothelial cells produce LMa5 and contribute to this basement
membrane, expression from only one of the two cell types is
sufficient for proper placental vascularization.80
LMa5 and Signaling Pathways
In addition to its mechanical role in maintaining the basement
membrane that provides structural support to cells and tissues,
LMa5 is also involved in signaling pathways that mediate























instructions for differentiation, migration or proliferation. Here
we will summarize what is currently known about this subject.
Through the study of developing organs, three major pathways
have been correlated with LMa5 activities: the Sonic Hedgehog
pathway, the Wnt pathway and the PI3Kinase/Akt pathway
(Fig. 3).
Sonic hedgehog (Shh) signaling. The Shh pathway plays a role
in multiple developmental processes by mediating interactions
between stromal and epithelial cells. The Shh pathway has three
effectors in mammalian cells: the Glioblastoma (Gli) transcription
factors Gli1, Gli2 and Gli3.81,82 The first direct demonstration of
a link between LMa5 and the Shh pathway was provided by Li
and colleagues in hair follicle development; they showed by in situ
hybridization that Shh and Gli1 were not expressed in the
embryonic Lama5-null skin, either before or after grafting, in
contrast to controls.67 In addition, grafting of LMa5 null skin
incubated with Shh-expressing adenovirus showed that the
exogenous Shh can rescue follicle regression.68 Likewise, in teeth,
the expression level of Shh mRNA was reduced in the enamel
knot region of the dental epithelium of LMa5-deficient mice,
which correlated with a reduction of cell proliferation.74
Interestingly, the abnormal lung lobar septation observed in the
Lama5-null mice resembled the defects observed in Gli2-null
mice.83 These experiments argue for a functional link between
LMa5 and the Shh pathway in at least two developing organs.
The Wnt pathway. During hair development, it was suggested
that Shh is not the only factor influenced by LM-511, as shown
by the existence of a signaling loop between Shh and noggin
coupled with Wnt/β-catenin activation.68 Gao and colleagues
showed that secreted LM-511, after interacting with β1 integrin,
leads to an increase of Shh; then the combined action of PDGF
and Shh signaling promotes expression of noggin, thus inhibiting
BMP signaling. This inhibition leads to Lef-1 expression, which,
coupled with the Wnt/β-catenin-induced activation, drives
further Shh expression.68 The relationship between the Wnt
pathway and LM-511, although indirect, has been confirmed by
the decreased expression of the downstream Wnt transcription
factor Lef-1 in the embryonic LMa5 null-skin.68 Furthermore,
when LMa5 null-mice were crossed with mice harboring Topgal,
a β-galactosidase transgene under control of a Lef/TCF and β-
catenin-inducible promoter, the skin showed a loss of Topgal
activation.68 Recently, a microarray analysis comparing deregu-
lated genes in LMa5 null vs. wild-type intestines revealed genes
that belong to the Wnt pathway, among which the Fzd2 Wnt
receptor and some Wnt targets such as Pitx2, Myod1 or Msx1
were upregulated in mutants. Activation of Wnt signaling in the
absence of LMa5 suggests that Wnt signaling is repressed in a
Lama5-expressing tissue. Indeed, in vitro TopFlash experiments
showed inhibition of Wnt signaling when intestinal epithelial cells
were seeded on LM-511 but not on LM-111.5 Mechanisms by
which LMa5 functions to regulate the Wnt pathway in the
intestine are not known, although one can argue for the
involvement of cellular receptors as some, such as β4 integrin
and Lutheran, were found to be altered.5
The PI3Kinase/Akt pathway. The PI3Kinase/Akt pathway is
known to be interconnected with the Wnt pathway through the
phosphorylation of its effecting factor Akt, which can stimulate β-
catenin.84 The PI3Kinase/Akt pathway regulates, among other
processes, cell growth and survival. The link between this pathway
and LMa5 was first demonstrated by an experiment in which
dental epithelium was allowed to grow on a LM-511/521
substratum with wortmannin, an inhibitor of PI3Kinase. Under
these conditions, filopodia formation was inhibited.74
Furthermore, in the intestine, expression of genes in this pathway
was altered in the absence of LMa5.5 It was then shown that Akt
was phosphorylated in vitro when epithelial intestinal cells were
seeded onto a LM-511 substratum. Through this pathway, LMa5
stimulated cell spreading and survival, as assessed by experiments
in which cells were seeded onto LM-511 with or without
wortmannin.5 Similarly, in vitro data provided a mechanistic link
between LM-511/LM-521 and cell survival, as cell adhesion to
the substratum, via the a3β1 integrin, was shown to trigger
phosphorylation of p130cas, leading to activation of downstream
cascades involving PI3K/Akt that prevents apoptosis.85
Conclusion and Perspectives
LMa5 is widely expressed in the organism and provides both
structural and functional support for interactions between
epithelium and mesenchyme.76 It has been shown that LMa5
transcripts, but not protein, decrease with aging, suggesting a
great stability of this molecule within the basement membrane
once organogenesis is complete.6 Moreover, LMa5 is deposited by
both epithelial and mesenchymal cells, and the origin of this
Figure 3. The LMa5 chain modulates signaling pathways. Three important signaling pathways have been described so far to be modulated by LMa5, as
shown by studies of LMa5-null mice, by microarray experiments, or in reporter assays (in vitro or in mice). These include Shh, Wnt/b-catenin and PI3K/Akt
pathways in the indicated tissues.























deposition varies throughout embryonic and perinatal life, at least
in the intestine.6,76 The lack of this LM chain leads to multiple
defects that can sometimes be rescued by compensatory
mechanisms with secretion and deposition of other LMa chains,
as observed in the intestine for example.34 As LMa5 is implicated
in divergent physiological processes such as adhesion, migration,
proliferation and differentiation, one can understand why distinct
signaling pathways can be engaged, in particular those employed
during morphogenesis and homeostasis of mature organs. At this
time, little is known about the exact mechanisms by which LMa5
regulates such signaling pathways, but there are likely to be
multiple cellular receptors involved. Future research will help to
further clarify the role of LMa5 in pathological processes, where
signals between epithelium and mesenchyme/fibroblasts are often
disrupted. Uncontrolled expression of this chain could also lead to
pathologies. Finally, increasing interest in LM−511 is illustrated
by its use as an efficient substratum for adhesion and self-renewal
of embryonic stem cells.
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